PED Q1 2026 Earnings Strong EPS Beat Highlights Operational Progress Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline CP Q1 2026 Earnings EPS Misses Estimates Stock Slips WFC Q1 2026 Earnings EPS Beats Estimates by a Narrow Margin Stock Edges Higher SLSN Q1 2026 Earnings Narrow Loss Reported Amid Quiet Quarter BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility